ClinicalTrials.govpublic full text
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
nasopharyngeal cancinoma (npc), recurrent nasopharynx carcinoma, metastatic nasopharyngeal carcinoma, egfr antibody, pd-1 antibody, chemotherapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804858
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.